IP Verse

Methods Of Treating Antibody-Mediated Rejection In Organ Transplant Patients With C1-Esterase Inhibitor

Patent No. EP3071219 (titled "Methods Of Treating Antibody-Mediated Rejection In Organ Transplant Patients With C1-Esterase Inhibitor") was filed by Shire Viropharma on Nov 21, 2014. The application was issued on Nov 14, 2018.

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
CSL INNOVATIONAug 14, 2019MEWBURN ELLIS

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP3071219

SHIRE VIROPHARMA
Application Number
EP14809567A
Filing Date
Nov 21, 2014
Status
Revoked
Jan 8, 2025
Publication Date
Nov 14, 2018
External Links
Slate, Register , Google Patents